Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunocore Holdings plc - American Depositary Shares (NQ:IMCR)

32.60 -0.33 (-1.00%)
Streaming Delayed Price Updated: 11:03 AM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immunocore Holdings plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary ↗
 
Via Benzinga
News headline image
Dow Climbs More Than 400 Points, S&P 500 Rises 1.5% ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 400 points on Friday. 
Via Benzinga
News headline image
Stocks Extend Gains, Weekly Wins In Sight ↗
Stocks are extending this morning's gains, with the Dow Jones Industrial Average last seen up 317 points. 
Via Talk Markets
News headline image
Analyzing Immunocore Hldgs's Short Interest ↗
Immunocore Hldgs's (NASDAQ:IMCR) short percent of float has fallen 15.71% since its last report. The company recently reported that it has 902 thousand shares sold short, which is... 
Via Benzinga
News headline image
Immunocore Shares Fall After Early Solid Cancer Trial Data Of TCR Therapy ↗
 
Via Benzinga
News headline image
Immunocore Eye Cancer Cell Therapy Scores European Approval ↗
The European Commission (EC)  
Via Benzinga
News headline image
FDA Approves First T Cell Receptor Therapy From Immunocore For Eye Cancer ↗
The  
Via Benzinga
News headline image
Why Zscaler Is Trading Higher By Around 19%, Here Are 44 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares jumped 70% to $2.1750 after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash. 
Via Benzinga
News headline image
Nasdaq Jumps Over 200 Points, Crude Oil Rises Sharply ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Friday. 
Via Benzinga
News headline image
Enphase Energy, Immunocore And Some Other Big Stocks Moving Lower On Friday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 300 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
US Stocks Open Higher, Dow Surges 300 Points ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Bed Bath & Beyond, Eiger BioPharmaceuticals And Some Other Big Stocks Moving Lower On Tuesday ↗
  
Via Benzinga
News headline image
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday ↗
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to... 
Via Benzinga
News headline image
15 Biotech Stocks That Hit Year Highs Over The Last Week, Including Sarepta, Axsome ↗
Not all shares are slowing down alongside the industry group. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022 ↗
  
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022 ↗
  
Via Benzinga
News headline image
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday ↗
U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
News headline image
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday ↗
U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022 ↗
Upgrades 
Via Benzinga
News headline image
The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Immunocore Commences Initial-Stage HIV Study ↗
Immunocore Holdings (NASDAQ: IMCR) has dosed the first patient in the first-in-human Phase 1 clinical trial of IMC-M113V for the treatment of patients with human immunodeficiency virus (HIV)... 
Via Benzinga
News headline image
4 Biotech Stocks With Bright Prospects To Buy Amid Recovery ↗
New drug approvals, acquisitions, and other pipeline developments are back in the spotlight in the biotech industry, following the focus on the development of vaccines and antibody treatments for... 
Via Talk Markets
News headline image
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus NuCana Discontinues Biliary Tract Cancer Study Following Futility Analysis... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Lilly's Co-developed Diabetes Drug Jardiance Gets Label Expansion To... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2022 ↗
Upgrades According to Consumer Edge Research, the prior rating for The Hain Celestial Group Inc (NASDAQ:HAIN) was changed from Equal-Weight to Overweight. For the second... 
Via Benzinga
News headline image
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates ↗
After a fairly robust 2021, the new year started on a mixed note as far as regulatory decisions are concerned. 
Via Benzinga
News headline image
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients ↗
Immunocore Holdings Plc (NASDAQ: IMCR) announced the initial Phase 1 data of IMC-C103C, a bispecific T cell engager targeting MAGE-A4, in selected advanced solid... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.